Biofrontera Inc. Payments of Stock Issuance Costs
Biofrontera Inc. (BFRI) reported Payments of Stock Issuance Costs of $3.10 million for the 0-month period ending 2021-11-02, per its 10-K filed 2023-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-13
- 2021-11-02: Payments of Stock Issuance Costs 0 month $3.10M.
- 2021-09-30: Payments of Stock Issuance Costs 9 month $638.00K.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 9 month |
|---|---|---|
| 2021-11-02 | $3.10M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $638.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |